Cetuximab as first-line treatment for metastatic colorectal cancer (mCRC): a model-based economic evaluation in Indonesia setting

OBJECTIVES: To assess the cost-effectiveness of cetuximab in combination with chemotherapy fluorouracil, oxaliplatin, and leucovorin (FOLFOX) or fluorouracil, irinotecan and leucovorin (FOLFIRI) compared to standard chemotherapy alone as a first-line treatment for metastatic colorectal cancer (mCRC)...

Descripción completa

Detalles Bibliográficos
Autores principales: Putri, Septiara, Saldi, Siti Rizny F., Khoe, Levina Chandra, Setiawan, Ery, Megraini, Amila, Santatiwongchai, Benjarin, Nugraha, Ryan R., Permanasari, Vetty Y., Nadjib, Mardiati, Sastroasmoro, Sudigdo, Armansyah, Armansyah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408081/
https://www.ncbi.nlm.nih.gov/pubmed/37553566
http://dx.doi.org/10.1186/s12885-023-11253-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408081/
https://www.ncbi.nlm.nih.gov/pubmed/37553566
http://dx.doi.org/10.1186/s12885-023-11253-y

Ejemplares similares